Topical calcineurin inhibitors in systemic lupus erythematosus
Christos E Lampropoulos, David P D’CruzLupus Research Unit, Rayne Institute, St. Thomas’ Hospital, London, UKAbstract: Cutaneous lupus erythematosus (CLE) encompasses a variety of lesions that may be refractory to systemic or topical agents. Discoid lupus erythematosus (D...
Main Authors: | Christos E Lampropoulos, David P D’Cruz |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-04-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/topical-calcineurin-inhibitors-in-systemic-lupus-erythematosus-a4243 |
Similar Items
-
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
by: Michael Sticherling
Published: (2011-02-01) -
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
by: Carlos Rafael-Vidal, et al.
Published: (2021-01-01) -
Consensus Statement on the Safety Profile of Topical Calcineurin Inhibitors
by: Bieber, Thomas, et al.
Published: (2014) -
Estradiol upregulates calcineurin expression via overexpression of estrogen receptor alpha gene in systemic lupus erythematosus
by: Hui-Li Lin, et al.
Published: (2011-04-01) -
Topical Calcineurin Inhibitors: Expanding Indications for Corneal and Ocular Surface Inflammation
by: Hamed Ghasemi, et al.
Published: (2019-10-01)